Palogic Value Management L.P. Raises Holdings in Health Catalyst, Inc. $HCAT

Key Points

• Palogic Value Management L.P. increased its stake in Health Catalyst, Inc. by 103.1% during Q1, now owning 650,000 shares valued at approximately $2.94 million.
• Several institutional investors, including SG Americas Securities and Invesco Ltd., have also significantly raised their positions in Health Catalyst, contributing to 85% institutional ownership of the company.
• The average price target for Health Catalyst has been set at $4.73, with recent ratings ranging from "buy" to "hold," reflecting analysts' mixed outlook on the stock.

Palogic Value Management L.P. grew its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 103.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 650,000 shares of the company's stock after buying an additional 330,000 shares during the period. Health Catalyst accounts for 1.3% of Palogic Value Management L.P.'s investment portfolio, making the stock its 25th largest position. Palogic Value Management L.P. owned about 0.93% of Health Catalyst worth $2,944,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. SG Americas Securities LLC lifted its position in shares of Health Catalyst by 195.2% during the 1st quarter. SG Americas Securities LLC now owns 80,825 shares of the company's stock valued at $366,000 after buying an additional 53,443 shares during the last quarter. Invesco Ltd. raised its stake in shares of Health Catalyst by 22.2% during the 1st quarter. Invesco Ltd. now owns 97,599 shares of the company's stock valued at $442,000 after purchasing an additional 17,725 shares during the period. BNP Paribas Financial Markets bought a new stake in shares of Health Catalyst during the 4th quarter valued at $735,000. Whetstone Capital Advisors LLC bought a new stake in shares of Health Catalyst during the 1st quarter valued at $7,724,000. Finally, Two Sigma Investments LP bought a new stake in shares of Health Catalyst during the 4th quarter valued at $496,000. Hedge funds and other institutional investors own 85.00% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Wells Fargo & Company decreased their price objective on Health Catalyst from $10.00 to $6.00 and set an "overweight" rating on the stock in a research note on Monday, August 11th. Citigroup lowered Health Catalyst from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $6.50 to $3.50 in a research note on Friday, August 8th. Stifel Nicolaus decreased their price objective on Health Catalyst from $5.50 to $4.50 and set a "hold" rating on the stock in a research note on Friday, August 8th. BTIG Research reiterated a "neutral" rating on shares of Health Catalyst in a research note on Friday. Finally, Piper Sandler lowered Health Catalyst from an "overweight" rating to a "neutral" rating and reduced their price objective for the company from $8.00 to $4.00 in a research report on Wednesday, August 27th. Three investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $4.73.

Health Catalyst Stock Performance

Shares of HCAT stock opened at $3.38 on Tuesday. The stock has a market capitalization of $237.85 million, a PE ratio of -2.24 and a beta of 1.53. Health Catalyst, Inc. has a 1-year low of $2.52 and a 1-year high of $9.24. The business has a 50-day moving average of $3.58 and a 200 day moving average of $3.90. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.83 and a quick ratio of 1.83.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

Want to see what other hedge funds are holding HCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Health Catalyst, Inc. (NASDAQ:HCAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.